RDA Financial Network grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.4% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,282 shares of the healthcare conglomerate’s stock after purchasing an additional 304 shares during the quarter. UnitedHealth Group makes up approximately 1.4% of RDA Financial Network’s holdings, making the stock its 13th biggest position. RDA Financial Network’s holdings in UnitedHealth Group were worth $4,861,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Waycross Partners LLC increased its holdings in UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after acquiring an additional 658 shares in the last quarter. Sherbrooke Park Advisers LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth $515,000. Full Sail Capital LLC lifted its stake in shares of UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after buying an additional 33 shares in the last quarter. Soros Fund Management LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth $39,413,000. Finally, Silvercrest Asset Management Group LLC lifted its position in shares of UnitedHealth Group by 47.8% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock valued at $19,625,000 after acquiring an additional 12,550 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Stock Up 2.5%
NYSE UNH opened at $303.24 on Friday. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The firm has a market capitalization of $275.08 billion, a price-to-earnings ratio of 19.56, a PEG ratio of 1.37 and a beta of 0.44. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a fifty day moving average of $409.03 and a two-hundred day moving average of $483.40.
UnitedHealth Group Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a $2.21 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.92%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.
Insider Activity
In other news, CEO Stephen J. Hemsley acquired 86,700 shares of the firm’s stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now directly owns 679,493 shares of the company’s stock, valued at $196,081,295.01. The trade was a 14.63% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of the company’s stock in a transaction on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
UNH has been the topic of several recent analyst reports. Robert W. Baird decreased their target price on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 14th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Wolfe Research cut their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research note on Tuesday, May 20th. TD Securities reissued a “hold” rating and set a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Finally, Morgan Stanley decreased their target price on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have issued a buy rating to the company. According to data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $428.43.
Get Our Latest Report on UnitedHealth Group
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- The Most Important Warren Buffett Stock for Investors: His Own
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Oversold Stocks Flashing Bullish Reversal Signals
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- With Novo Nordisk’s CEO Out, Wall Street Wants an American Leader
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.